NGI-235 is a selectiveOST-Ainhibitor that inhibitsNF-κBinflammatory signaling by blockingTLR4glycosylation[1].
References:
[1].Lampson BL, et al. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB. Cell. 2024 Apr 25;187(9):2209-2223.e16.
NGI-235 是一种选择性的OST-A抑制剂,通过阻断TLR4糖基化抑制NF-κB炎症信号。
















